Severe fingolimod rebound syndrome after switching to cladribine treatment

被引：10

作者：

Coss-Rovirosa, Fernanda ^{[1
]}

Salado-Burbano, Jorge ^{[1
]}

Casallas-Vanegas, Adriana ^{[2
]}

Elizabeth Caire-Herrera, Laura ^{[3
]}

Gomez-Figueroa, Enrique ^{[1
,2
]}

Flores-Rivera, Jose ^{[1
,2
]}

机构：

[1] Amer British Cowdray Med Ctr, Mexico City, DF, Mexico

[2] Inst Nacl Neurol & Neurocirug, Mexico City, DF, Mexico

[3] Hosp Psiquiatr Infanta Juan N Navarro, Mexico City, DF, Mexico

来源：

MULTIPLE SCLEROSIS AND RELATED DISORDERS | 2020年 / 40卷

关键词：

Fingolimod; Rebound; Cladribine; Multiple sclerosis; MULTIPLE-SCLEROSIS; DISEASE REACTIVATION;

D O I：

10.1016/j.msard.2020.101938

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

We present the clinical and imaging characteristics of a patient whom presented with rebound syndrome after switching from fingolimod to cladribine treatment due to hematologic toxicity. Previous imaging studies had shown a non-aggressive phenotype of the disease, however multiple active tumefactive lesions became evident after beginning treatment with cladribine. The patient responded well to plasmapheresis.

引用

页数：3

共 50 条

[41] Rebound of multiple sclerosis activity during pregnancy after fingolimod withdrawal
Rua, A.
Sola Valls, N.
Sepulveda, M.
Blanco, Y.
Llufriu, S.
Saiz, A.
EUROPEAN JOURNAL OF NEUROLOGY, 2016, 23 : 819 - 819
[42] Frequency and risk factors of rebound after fingolimod discontinuation - A retrospective study
Maunula, A.
Atula, S.
Laakso, Sm
Tienari, Pj
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2024, 81
[43] Fingolimod withdrawalRebound syndrome after the withdrawal of fingolimod: case report
Reactions Weekly, 2019, 1750 (1) : 126 - 126
[44] Fingolimod cessation and multiple sclerosis rebound syndrome: a case report and literature review
dos Passos, G.
Geraldes, R.
Rigozzi, C.
Monaghan, P.
DeLuca, G. C.
MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 942 - 943
[45] REBOUND EFFECT AFTER SOMATOSTATIN TREATMENT IN VERNER-MORRISON SYNDROME
BONFILS, S
RENE, E
PIGNAL, F
RAMBAUD, JC
LANCET, 1979, 2 (8140): : 476 - 476
[46] Rebound of disease activity after fingolimod withdrawal: Immunological and gene expression profiling
Sacco, Rosaria
Emming, Stefan
Gobbi, Claudio
Zecca, Chiara
Monticelli, Silvia
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 40
[47] Rebound after Fingolimod suspension in a pediatric-onset multiple sclerosis patient
Piscolla, E.
Hakiki, B.
Pasto, L.
Razzolini, L.
Portaccio, E.
Amato, M. P.
JOURNAL OF NEUROLOGY, 2013, 260 (06) : 1675 - 1677
[48] Rebound after Fingolimod suspension in a pediatric-onset multiple sclerosis patient
E. Piscolla
B. Hakiki
L. Pastò
L. Razzolini
E. Portaccio
M. P. Amato
Journal of Neurology, 2013, 260 : 1675 - 1677
[49] Rebound in disease activity after fingolimod suspension for pregnancy planning: predictor factors
Sepulveda, M.
Blanco, Y.
Montejo, C.
Sola-Valls, N.
Zubizarreta, I.
Pulido-Valdeolivas, I.
Arino, H.
Martinez-Lapiscina, E. H.
Martinez-Hernandez, E.
Llufriu, S.
Saiz, A.
MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 776 - 776
[50] Rebound of disease activity after fingolimod (FTY) withdrawal: can we predict it?
Dotor Garcia-Soto, Julio
Meca Lallana, Virginia
Quintas, Sonia
Vivancos Mora, Jose A.
NEUROLOGY, 2018, 90

← 1 2 3 4 5 →